BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27502848)

  • 1. Impact of baseline mitral regurgitation on short- and long-term outcomes following transcatheter aortic valve replacement.
    Kiramijyan S; Magalhaes MA; Koifman E; Didier R; Escarcega RO; Minha S; Baker NC; Negi SI; Torguson R; Gai J; Okubagzi P; Asch FM; Gaglia MA; Ben-Dor I; Satler LF; Pichard AD; Waksman R
    Am Heart J; 2016 Aug; 178():19-27. PubMed ID: 27502848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A.
    Barbanti M; Webb JG; Hahn RT; Feldman T; Boone RH; Smith CR; Kodali S; Zajarias A; Thompson CR; Green P; Babaliaros V; Makkar RR; Szeto WY; Douglas PS; McAndrew T; Hueter I; Miller DC; Leon MB;
    Circulation; 2013 Dec; 128(25):2776-84. PubMed ID: 24152861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Functional Versus Organic Baseline Mitral Regurgitation on Short- and Long-Term Outcomes After Transcatheter Aortic Valve Replacement.
    Kiramijyan S; Koifman E; Asch FM; Magalhaes MA; Didier R; Escarcega RO; Negi SI; Baker NC; Jerusalem ZD; Gai J; Torguson R; Okubagzi P; Wang Z; Shults CC; Ben-Dor I; Corso PJ; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2016 Mar; 117(5):839-46. PubMed ID: 26873331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitral Regurgitation After Transcatheter Aortic Valve Replacement: Prognosis, Imaging Predictors, and Potential Management.
    Cortés C; Amat-Santos IJ; Nombela-Franco L; Muñoz-Garcia AJ; Gutiérrez-Ibanes E; De La Torre Hernandez JM; Córdoba-Soriano JG; Jimenez-Quevedo P; Hernández-García JM; Gonzalez-Mansilla A; Ruano J; Jimenez-Mazuecos J; Castrodeza J; Tobar J; Islas F; Revilla A; Puri R; Puerto A; Gómez I; Rodés-Cabau J; San Román JA
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1603-14. PubMed ID: 27491611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in mitral regurgitation severity impacts survival after transcatheter aortic valve replacement.
    Feldt K; De Palma R; Bjursten H; Petursson P; Nielsen NE; Kellerth T; Jönsson A; Nilsson J; Rück A; Settergren M
    Int J Cardiol; 2019 Nov; 294():32-36. PubMed ID: 31399298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation.
    Toggweiler S; Boone RH; Rodés-Cabau J; Humphries KH; Lee M; Nombela-Franco L; Bagur R; Willson AB; Binder RK; Gurvitch R; Grewal J; Moss R; Munt B; Thompson CR; Freeman M; Ye J; Cheung A; Dumont E; Wood DA; Webb JG
    J Am Coll Cardiol; 2012 Jun; 59(23):2068-74. PubMed ID: 22483326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of mitral regurgitation by an integrated 2D echocardiographic approach in patients undergoing transcatheter aortic valve replacement.
    Jansen R; Wind AM; Cramer MJ; Nijhoff F; Agostoni P; Ramjankhan FZ; Suyker WJ; Stella PR; Chamuleau SAJ
    Int J Cardiovasc Imaging; 2018 Aug; 34(8):1193-1204. PubMed ID: 29524077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of mitral and tricuspid regurgitation in patients with severe aortic stenosis.
    Zilberszac R; Gleiss A; Binder T; Laufer G; Grimm M; Gabriel H; Maurer G; Rosenhek R
    Eur Heart J Cardiovasc Imaging; 2018 Sep; 19(9):985-992. PubMed ID: 29506023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fate and long-term prognostic implications of mitral regurgitation in patients undergoing transcatheter aortic valve replacement.
    Abdelghani M; Abdel-Wahab M; Hemetsberger R; Landt M; Merten C; Toelg R; Richardt G
    Int J Cardiol; 2019 Aug; 288():39-43. PubMed ID: 30948219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR: Insights From the TOPAS-TAVI Registry.
    Freitas-Ferraz AB; Lerakis S; Barbosa Ribeiro H; Gilard M; Cavalcante JL; Makkar R; Herrmann HC; Windecker S; Enriquez-Sarano M; Cheema AN; Nombela-Franco L; Amat-Santos I; Muñoz-García AJ; Garcia Del Blanco B; Zajarias A; Lisko JC; Hayek S; Babaliaros V; Le Ven F; Gleason TG; Chakravarty T; Szeto WY; Clavel MA; de Agustin A; Serra V; Schindler JT; Dahou A; Annabi MS; Pelletier-Beaumont E; Pibarot P; Rodés-Cabau J
    JACC Cardiovasc Interv; 2020 Mar; 13(5):567-579. PubMed ID: 32061600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement.
    Mauri V; Körber MI; Kuhn E; Schmidt T; Frerker C; Wahlers T; Rudolph TK; Baldus S; Adam M; Ten Freyhaus H
    Clin Res Cardiol; 2020 Oct; 109(10):1261-1270. PubMed ID: 32072263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between mitral regurgitation and transcatheter aortic valve replacement with the CoreValve Revalving System: a multicenter registry.
    Bedogni F; Latib A; De Marco F; Agnifili M; Oreglia J; Pizzocri S; Latini RA; Lanotte S; Petronio AS; De Carlo M; Ettori F; Fiorina C; Poli A; Cirri S; De Servi S; Ramondo A; Tarantini G; Marzocchi A; Fiorilli R; Klugmann S; Ussia GP; Tamburino C; Maisano F; Brambilla N; Colombo A; Testa L
    Circulation; 2013 Nov; 128(19):2145-53. PubMed ID: 24088530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degenerative mitral regurgitation predicts worse outcomes in patients undergoing transcatheter aortic valve replacement.
    Kindya B; Ouzan E; Lerakis S; Gonen E; Babaliaros V; Karayel E; Thourani VH; Gotsman I; Devireddy CM; Danenberg HD; Leshnower BG; Beeri R; Ko YA; Gilon D; Ahmed H; Liu C; Lotan C; Mavromatis K
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):574-582. PubMed ID: 29602220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis and Mitral Regurgitation.
    Mavromatis K; Thourani VH; Stebbins A; Vemulapalli S; Devireddy C; Guyton RA; Matsouaka R; Ghasemzadeh N; Block PC; Leshnower BG; Stewart JP; Rumsfeld JS; Lerakis S; Babaliaros V
    Ann Thorac Surg; 2017 Dec; 104(6):1977-1985. PubMed ID: 28965619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Transcatheter Aortic Valve Replacement on Concomitant Mitral Regurgitation and Its Impact on Mortality.
    Witberg G; Codner P; Landes U; Schwartzenberg S; Barbanti M; Valvo R; De Backer O; Ooms JF; Islas F; Marroquin L; Sedaghat A; Sugiura A; Masiero G; Werner P; Armario X; Fiorina C; Arzamendi D; Santos-Martinez S; Fernández-Vázquez F; Baz JA; Steblovnik K; Mauri V; Adam M; Merdler I; Hein M; Ruile P; Grasso C; Branca L; Estévez-Loureiro R; Benito-González T; Amat-Santos IJ; Mylotte D; Andreas M; Bunc M; Tarantini G; Sinning JM; Nombela-Franco L; Søndergaard L; Van Mieghem NM; Finkelstein A; Kornowski R
    JACC Cardiovasc Interv; 2021 Jun; 14(11):1181-1192. PubMed ID: 33992550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tricuspid but not Mitral Regurgitation Determines Mortality After TAVI in Patients With Nonsevere Mitral Regurgitation.
    Amat-Santos IJ; Castrodeza J; Nombela-Franco L; Muñoz-García AJ; Gutiérrez-Ibanes E; de la Torre Hernández JM; Córdoba-Soriano JG; Jiménez-Quevedo P; Hernández-García JM; González-Mansilla A; Ruano J; Tobar J; Del Trigo M; Vera S; Puri R; Hernández-Luis C; Carrasco-Moraleja M; Gómez I; Rodés-Cabau J; San Román JA
    Rev Esp Cardiol (Engl Ed); 2018 May; 71(5):357-364. PubMed ID: 29079280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of moderate to severe mitral stenosis in patients undergoing transcatheter aortic valve replacement.
    Fischer Q; Himbert D; Bernier M; Urena M; Nunes Ferreira-Neto A; Paradis JM; Mohammadi S; Iung B; Rodés-Cabau J
    Int J Cardiol; 2019 Jul; 286():36-42. PubMed ID: 30967274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry.
    Hira RS; Vemulapalli S; Li Z; McCabe JM; Rumsfeld JS; Kapadia SR; Alam M; Jneid H; Don C; Reisman M; Virani SS; Kleiman NS
    JAMA Cardiol; 2017 Aug; 2(8):846-854. PubMed ID: 28636718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant Reduction in Mitral Regurgitation Volume Is the Main Contributor for Increase in Systolic Forward Flow in Patients with Functional Mitral Regurgitation after Transcatheter Aortic Valve Replacement: Hemodynamic Analysis Using Echocardiography.
    Itabashi Y; Shibayama K; Mihara H; Utsunomiya H; Berdejo J; Arsanjani R; Siegel R; Chakravarty T; Jilaihawi H; Makkar RR; Shiota T
    Echocardiography; 2015 Nov; 32(11):1621-7. PubMed ID: 25817306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement.
    Barbanti M; Binder RK; Dvir D; Tan J; Freeman M; Thompson CR; Cheung A; Wood DA; Leipsic J; Webb JG
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):677-84. PubMed ID: 24740834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.